sf2a-tt15 vaccine
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2016 (NCT02797236)
Timeline
Indications
Mechanism of action
- Shigella flexneriImmunity, active
Shigella flexneri immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- sf2a-tt15 vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04078022 | Phase 2 | Sep 30, 2019 | University of Maryland |
| NCT02797236 | Phase 1 | Jun 1, 2016 | Institut Pasteur |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Institut Pasteur | Academic/Hospital | 1 | 1 | 1 | 2016 |
| University of Maryland | Academic/Hospital | 1 | 1 | 1 | 2019 |
2 organizations
Page 1 / 1